344 related articles for article (PubMed ID: 19397221)
1. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
Ross LE; Taylor YJ; Richardson LC; Howard DL
J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States.
Tourville EA; Nguyen MM
Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941
[TBL] [Abstract][Full Text] [Related]
3. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
[TBL] [Abstract][Full Text] [Related]
4. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
Hattangadi JA; Chen MH; D'Amico AV
BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
[TBL] [Abstract][Full Text] [Related]
5. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
6. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
7. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
[TBL] [Abstract][Full Text] [Related]
8. Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysis.
Garg V; Raisch DW; Selig JP; Thompson TA
Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):193-203. PubMed ID: 23399779
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen test use and digital rectal examinations among African-American men, 2002-2006.
Ross LE; Meade SA; Powe BD; Howard DL
J Natl Black Nurses Assoc; 2009 Jul; 20(1):52-8. PubMed ID: 19691184
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of usefulness of prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer in an unscreened population:experience in a Nigerian teaching hospital.
Ojewola RW; Tijani KH; Jeje EA; Ogunjimi MA; Anunobi CC; Adesanya AO
West Afr J Med; 2013; 32(1):8-13. PubMed ID: 23613288
[TBL] [Abstract][Full Text] [Related]
11. Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume.
Chiu PK; Roobol MJ; Teoh JY; Lee WM; Yip SY; Hou SM; Bangma CH; Ng CF
Int Urol Nephrol; 2016 Oct; 48(10):1631-7. PubMed ID: 27349564
[TBL] [Abstract][Full Text] [Related]
12. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
13. Digital rectal examination is barrier to population-based prostate cancer screening.
Nagler HM; Gerber EW; Homel P; Wagner JR; Norton J; Lebovitch S; Phillips JL
Urology; 2005 Jun; 65(6):1137-40. PubMed ID: 15922431
[TBL] [Abstract][Full Text] [Related]
14. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997.
Roberts RO; Bergstralh EJ; Lieber MM; Jacobsen SJ
Urology; 2000 Nov; 56(5):817-22. PubMed ID: 11068309
[TBL] [Abstract][Full Text] [Related]
15. Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; van den Bergh RC; Wolters T; Schröder FH
Eur Urol; 2009 Jan; 55(1):139-46. PubMed ID: 18406045
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
[TBL] [Abstract][Full Text] [Related]
17. Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.
Walsh AL; Considine SW; Thomas AZ; Lynch TH; Manecksha RP
Br J Gen Pract; 2014 Dec; 64(629):e783-7. PubMed ID: 25452543
[TBL] [Abstract][Full Text] [Related]
18. The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy.
Issa MM; Zasada W; Ward K; Hall JA; Petros JA; Ritenour CW; Goodman M; Kleinbaum D; Mandel J; Marshall FF
Cancer Detect Prev; 2006; 30(3):269-75. PubMed ID: 16844319
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
20. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
Thompson IM; Pauler Ankerst D; Chi C; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
J Clin Oncol; 2007 Jul; 25(21):3076-81. PubMed ID: 17634486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]